[Device name] from FDA clearance to first commercial sale
[Brief 2-3 sentence description of the launch. What device, what stage, what we did. Brett to fill in.]
You built the instrument. We’ll build the business that sells it.
For technical founders and C-level teams, pre-seed to Series B, with small, limited, or no commercial team.
You keep the science. We take the market.
35+ years and 25+ launches, working from day one. No twelve-month build, no equity grant, no bad hire to unwind.
30,000+ scientists and KOLs across flow cytometry, bioprocess, and metabolic research. The people who decide whether your category adopts.
CDMO and supply chain networks across the Americas, EU, and Asia, so making the units is never the thing that stalls the launch.
Companies we’ve worked with have raised $150M+. At pre-seed to Series B, commercial traction is what the term sheet is built on.
[Brief 2-3 sentence description of the launch. What device, what stage, what we did. Brett to fill in.]
[Brief 2-3 sentence description. What the asset was, what we ran, what closed. Brett to fill in.]
[Brief 2-3 sentence description. What the tool was, how we structured distribution, what scaled. Brett to fill in.]
No handoffs between specialists. No disappearing between phases.
Define the market, the buyer, the commercial model, and the milestone-based roadmap. Translate your science into the right path to revenue.
Launch planning, pricing, reimbursement, channel strategy, and field readiness. Everything that turns a cleared product into commercial scale.
Identify, evaluate, and negotiate partnerships, licensing deals, and collaborations that expand capabilities and unlock strategic growth.
Global manufacturing networks, CMO/CDMO selection, scale-up readiness, and distribution partnerships across the Americas, EU, and Asia.
Microbioreactors and nanoparticle analysis platforms we have commercialized for the technology developers behind them.
Accelerate Cell Line Development by 29 to 42 percent with true dynamic mixing at 24- and 96-well scale. Real-time DO and pH metabolic insight at the microplate stage.
Request DetailsSee metabolism in motion. Continuously monitor DO, pH, OCR, and ECAR in real time for full-course metabolic profiling throughout the entire culture period.
Request DetailsThree founders. Decades of senior leadership across pharma, biotech, and diagnostics. The team you meet is the team you work with.
Strategy, commercialization, and capital. Multi-product launches across pharma and life science tools.
Operations, manufacturing, and global distribution. Decades scaling life science companies through launch and beyond.
Licensing, partnerships, and business development across biotech, diagnostics, and life science tools.
A 12-point self-assessment built from 20+ life science launches. Use it to evaluate whether your product is ready for commercial launch.